Steward Partners Investment Advisory’s Amphastar Pharmaceuticals AMPH Stock Holding History

Steward Partners Investment Advisory’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.96K	Buy	+100	New	+$2.45K	﹤0.01%	4061
2024 Q4	–	Sell	-400	Closed	-$19.4K	–	3974
2024 Q3	$19.4K	Sell	400 -250	-38%	-$11K	﹤0.01%	2671
2024 Q2	$26K	Buy	650 +400	+160%	+$16.6K	﹤0.01%	2409
2024 Q1	$11K	Hold	250	–	–	﹤0.01%	2774
2023 Q4	$15.5K	Hold	250	–	–	﹤0.01%	2521
2023 Q3	$11.5K	Buy	+250	New	+$13.6K	﹤0.01%	2540
2020 Q1	–	Sell	-1	Closed	–	–	2479
2019 Q4	$0	Hold	1	–	–	﹤0.01%	2581
2019 Q3	$0	Hold	1	–	–	﹤0.01%	2607
2019 Q2	$0	Buy	+1	New	+$21	﹤0.01%	2603

Other funds holding AMPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

Steward Partners Investment Advisory's AMPH Position: Q1 2026 in Review

Steward Partners Investment Advisory opened a new position in Amphastar Pharmaceuticals (AMPH) in Q1 2026: 100 shares worth $1.96K. The stake represents ﹤0.01% of the portfolio and ranks #4061 among its holdings. This is a return to the name: Steward Partners Investment Advisory previously reported a position in AMPH as recently as Q3 2024.

Steward Partners Investment Advisory first reported a position in AMPH in Q2 2019 and has held it in 9 quarters since. The position peaked at $26K in Q2 2024. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.

Steward Partners Investment Advisory held 100 shares of Amphastar Pharmaceuticals worth $1.96K as of Q1 2026.
Amphastar Pharmaceuticals was a new Steward Partners Investment Advisory position in Q1 2026.
Amphastar Pharmaceuticals made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q1 2026, its #4061 holding.
Steward Partners Investment Advisory first reported a position in Amphastar Pharmaceuticals in Q2 2019 and has held it in 9 quarters since.
Steward Partners Investment Advisory's Amphastar Pharmaceuticals position peaked at $26K in Q2 2024.
215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.